We are live on ! Find out more
VPW

Vericrest Private Wealth Portfolio holdings

AUM $111M
This Fund
S&P 500
This Quarter Est. Return
-11.84%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$81.5M
AUM Growth
-$14.7M
Cap. Flow
-$3.19M
Cap. Flow %
-3.91%
Top 10 Hldgs %
56.05%
Holding
40
New
1
Increased
9
Reduced
16
Closed
1

Top Buys

Rank Stock Value
1
DTIL icon
Precision BioSciences
DTIL
+$303K
2
FLRN icon
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
+$219K
3
PCY icon
Invesco Emerging Markets Sovereign Debt ETF
PCY
+$208K
4
DGRO icon
iShares Core Dividend Growth ETF
DGRO
+$105K
5
SPYD icon
State Street SPDR Portfolio S&P 500 High Dividend ETF
SPYD
+$96.5K

Top Sells

Rank Stock Value
1
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$1.53M
2
PHAS
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
+$1.39M
3
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$301K
4
MUB icon
iShares National Muni Bond ETF
MUB
+$168K
5
IVV icon
iShares Core S&P 500 ETF
IVV
+$144K

Sector Composition

Rank Sector Weight
1 Technology 6.29%
2 Communication Services 1.65%
3 Healthcare 0.61%
4 Financials 0.59%
5 Consumer Discretionary 0.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
META icon
26
Meta Platforms (Facebook)
META
$1.51T
$911K 1.12%
5,651
– –
SPYD icon
27
State Street SPDR Portfolio S&P 500 High Dividend ETF
SPYD
$7.66B
$766K 0.94%
19,184
+2,244
+13% +$96.5K
XLE icon
28
State Street Energy Select Sector SPDR ETF
XLE
$39.5B
$660K 0.81%
18,448
– –
VCR icon
29
Vanguard Consumer Discretionary ETF
VCR
$5.84B
$594K 0.73%
2,613
– –
JPM icon
30
JPMorgan Chase
JPM
$939B
$477K 0.59%
4,237
– –
GOOGL icon
31
Alphabet (Google) Class A
GOOGL
$3.91T
$431K 0.53%
3,960
– –
ITA icon
32
iShares US Aerospace & Defense ETF
ITA
$14.2B
$383K 0.47%
3,860
– –
SHY icon
33
iShares 1-3 Year Treasury Bond ETF
SHY
$25.4B
$374K 0.46%
4,520
-207
-4% -$17.2K
VGT icon
34
Vanguard Information Technology ETF
VGT
$139B
$274K 0.34%
6,720
– –
DTIL icon
35
Precision BioSciences
DTIL
$188M
$248K 0.3%
+5,156
New +$303K
PFE icon
36
Pfizer
PFE
$140B
$247K 0.3%
4,715
– –
CPNG icon
37
Coupang
CPNG
$27.8B
$229K 0.28%
17,970
– –
ED icon
38
Consolidated Edison
ED
$41.6B
$226K 0.28%
2,374
– –
SPAB icon
39
State Street SPDR Portfolio Aggregate Bond ETF
SPAB
$9.78B
$206K 0.25%
7,806
-924
-11% -$24.6K
PHAS
40
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
– –
-1,051,940
Closed -$1.39M
1
2

Similar funds

EGP
Emergence GP Partners San Francisco, California $111M AUM 28.73% 1-Year Est. Return
FA
Fountainhead AM Warren, New Jersey $111M AUM 16.78% 1-Year Est. Return
LP
LB Partners Charlottesville, Virginia $112M AUM 11% 1-Year Est. Return
WWMP
Wagner Wealth Management (Pennsylvania) Conyngham, Pennsylvania $111M AUM
FCU
Financial Concepts Unlimited Centreville, Maine $112M AUM
HCM
Hestia Capital Management Cranberry Township, Pennsylvania $111M AUM 21.99% 1-Year Est. Return
OCA
Odyssey Capital Advisors Bala Cynwyd, Pennsylvania $112M AUM
NIM
Niles Investment Management Plantation, Florida $111M AUM

Vericrest Private Wealth's Q2 2022 Portfolio in Review

As of Q2 2022, Vericrest Private Wealth held 40 positions worth $81.5M, down 15% from $96.2M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Vericrest Private Wealth withdrew a net $3.19M in Q2 2022, closing 1 position and reducing 16 holdings. Its most notable exit was PhaseBio Pharmaceuticals, Inc. Common Stock, an estimated $1.39M position sold in full.

By sector, the portfolio is most concentrated in Technology at 6.3% of assets, down from 6.7% a quarter earlier, followed by Communication Services and Healthcare.

Against the trend, Vericrest Private Wealth opened a new position in Precision BioSciences worth $248K.

  • Vericrest Private Wealth's largest Q2 2022 buy was Precision BioSciences: 5,156 shares worth $248K.
  • Vericrest Private Wealth added most to State Street SPDR Bloomberg Investment Grade Floating Rate ETF in Q2 2022, an estimated $219K increase.
  • Vericrest Private Wealth's biggest Q2 2022 reduction was iShares Core US Aggregate Bond ETF, cutting an estimated $1.53M.
  • Vericrest Private Wealth fully exited PhaseBio Pharmaceuticals, Inc. Common Stock in Q2 2022, selling an estimated $1.39M.
  • Vericrest Private Wealth's ten largest holdings make up 56% of its $81.5M portfolio in Q2 2022.
  • Vericrest Private Wealth opened 1 new position and closed 1 in Q2 2022.
  • Vericrest Private Wealth's portfolio value fell 15% quarter-over-quarter to $81.5M.

Based on Vericrest Private Wealth's 13F filing for Q2 2022, filed 15 Aug 2022.